SA Tuberculosis Vaccine Initiative

Search

Community Engagement

In March 2016 SATVI brought "Lienkie se Longe", a drama to raise awareness about TB, to the Worcester Easter Festival. The drama tells the story of Lienkie, whose lungs “talk with each other’ about their health and the health of Lienkie’s boyfriend...

Biomarker discovery offers hope for new TB vaccine development

A team of scientists from the University of Cape Town, Oxford University and the London School of Hygiene & Tropical Medicine have made a discovery that reveals how we can improve development of more effective vaccines against tuberculosis.

Community Engagement

In 2012 SATVI developed a drama production to promote awareness about TB vaccine clinical research, titled “Carina’s Choice” with learners from Worcester Secondary School as actors and UCT drama school students as mentors. A very successful roadshow...

Accredited UCT Research Centre

The South African Tuberculosis Vaccine Initiative (SATVI) is an accreditated Research Centre of the University of Cape Town.

Kick TB Schools Program 17- 27 May 2016

On Tuesday 17 May 2016, SATVI kicked off a districtwide TB awareness raising program, in partnership with TB Alliance, the Western Cape Education Department, AERAS, TB Care (USAID), in Robertson.

News

Sunday, 23 July 2017

17 July 2017 LATEST RESEARCH: Cross-species Mycobacterial Inhibition Assay Project 2010 -2014

SATVI authors Tom Scriba, Adam Penn-Nicholson and Mwandile Erasmus have co-authored a research paper titled "The Crosspecies Mycobacterial Growth Inhibition Assay (MGIA) Project 2010-2014" appearing in the Clinical and Vaccine Immunology journal.

Publication Date:

Monday, July 17, 2017 - 09:45

6 July 2017 Research: Impact of Isoniazid preventive therapy on the evaluation of long-term effectiveness of infant MVA85A vaccination

SATVI authors have published an article titled “Impact of Isoniazid preventive therapy on the evaluation of long-term effectiveness of infant MVA85A vaccination” appearing in the International Journal of Tuberculosis and Lung Disease.

Publication Date:

Thursday, July 6, 2017 - 12:30

29 June 2017 SATVI says farewell to Dr Hennie Geldenhuys

Staff and students of the South African Tuberculosis Vaccine Initiative (SATVI) recently bid farewell to Doctor Hennie Geldenhuys, who will depart from SATVI at the end of June 2017.

Publication Date:

Wednesday, June 28, 2017 - 22:30

26 June 2017 Research: Identifying specificity groups in the T cell receptor repertoire

Associate Professor Thomas Scriba has co-authored a research paper titled "Identifying specificity groups in the T cell receptor repertoire" appearing in the Nature Journal.

Publication Date:

Monday, June 26, 2017 - 13:30